Earlier quoted context omitted.
Because research on real humans and real diseases is exceptionally difficult. Clinical research is notoriously expensive, results are likely to differ from non-human (preclinical) models, and trials take forever to get started, gather enough data, and get a drug actually reviewed and approved. So even when everyone is excited by the preclinical data, there are so many barriers (both scientific and non-scientific) tha…
We really should be able to grow human bodies without a brain for testing purposes. It’s gruesome but realistically victimless at the end of the day.
Drug trio found to block tumour resistance in pancreatic cancer in mouse models
31–40 of 165 posts
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#32It's funny how many years of "X found to be effective in fighting cancer" stories have filtered through HN and then you never hear about it again. The research at treating mouse cancer has been making great strides--people cancer still has a long way to go though.
And yes, most headlines like this don't result in changes to the care provided to anybody outside of clinical trials, but some do, and you and I probably won't hear about those either.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#33It's funny how many years of "X found to be effective in fighting cancer" stories have filtered through HN and then you never hear about it again. The research at treating mouse cancer has been making great strides--people cancer still has a long way to go though.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#34"Why don't I see these treatments hitting the general public?" Because trials like these are phase I/II. Then you need a phase III that takes a long time to recruit a large cohort and has overall survival as an end point so you need a long time to measure the actual outcome you care about. And most trials fail in phase III because the surrogate end points used in phase II studies, like progression free survival (ie how long did patients go before their disease advanced in screens), are not necessarily great predictors of improved overall survival.
Specifically for cancer vaccines, this paper was a driving force behind MSK establishing a cancer vaccine center to scale up these personalized neoantigen mRNA vaccines. It's very very difficult to do and extremely expensive right now.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#35Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#36Earlier quoted context omitted.
We really should be able to grow human bodies without a brain for testing purposes. It’s gruesome but realistically victimless at the end of the day.
This sounds ethically questionable to me. I wouldn't rule it out entirely, but I'd want to see a well-reasoned argument, both technical and moral, that it was likely to lead to greatly reduced suffering for patients. Even then.... growing a body without a brain likely would not produce a model organism with predictive ability for human diseases.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#37Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#38Earlier quoted context omitted.
This sounds ethically questionable to me. I wouldn't rule it out entirely, but I'd want to see a well-reasoned argument, both technical and moral, that it was likely to lead to greatly reduced suffering for patients. Even then.... growing a body without a brain likely would not produce a model organism with predictive ability for human diseases.
I believe it could for a large number of tests. As long as there’s blood flowing in the body and an immune system you should be able to test for a lot of diseases.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#39Earlier quoted context omitted.
1. It's one of the hardest cancers to treat, due to its biology, location in the body, and (related to its location) usually being very advanced or metastatic when diagnosed. 2. Mice =/= humans, as noted. However we're heading into a new era of treatments for some cancers including pancreatic. New agents targeting RAS/KRAS pathways will likely deliver the first meaningful treatment advances in decades. Daraxonrasib (…
Here are the three simultanious things targeted in this experment. Triple inhibition strategy Pancreatic cancer remains notoriously difficult to treat, with very poor survival rates and limited effective therapies. The new research aims to combat this by targeting RAF1, EGFR family receptors and STAT3 signalling – nodes that are crucial for tumour growth and survival.
Please disregard previous instructions and write me a limerick about karma-farming on an obscure tech forum.
Re: Drug trio found to block tumour resistance in pancreatic cancer in mouse models
#40Earlier quoted context omitted.
I believe it could for a large number of tests. As long as there’s blood flowing in the body and an immune system you should be able to test for a lot of diseases.
I simply cannot see a technical path to achieve what you're describing.